XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 32.31

+1.4%

Nov 26 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robert K. who wrote (7771)	11/19/1998 8:01:00 PM
From: Robert S.	Read Replies (2) of 17367

RobertK, thanks for the information from the abstract you posted. If we accept that BPI neutralizes cytokines, how then does this address other immune system components such as eicosanoids, complement components, and/or kinins? To complicate matters, it appears that cytokines play both pathogenic and protective roles; hence, the dilemma in combating such a complex disease. Message 6356208

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next